NUVB
The table below shows Nuvation Bio Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $125.39M | $98.90M | $247.97M | $47.98M | $30.04M | $34.28M |
| Short-term investments | $408.34M | $450.15M | $359.75M | $413.70M | $519.10M | $542.88M |
| Receivables | - | - | - | - | - | - |
| Inventory | $15.84M | $5.71M | $552.00K | $14.00K | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $591.53M |
| $577.53M |
| $623.21M |
| $475.57M |
| $564.99M |
| $587.17M |
| Property, plant & equipment | $535.00K | $560.00K | $615.00K | $562.00K | $719.00K | $751.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $610.24M | $601.56M | $647.23M | $492.49M | $571.58M | $594.80M |
| Accounts payable | $22.43M | $15.36M | $22.42M | $10.54M | $12.38M | $5.21M |
| Total current liabilities | $79.52M | $68.13M | $66.36M | $52.77M | $59.03M | $51.09M |
| Long-term debt | $47.33M | $47.09M | $46.97M | - | - | - |
| Total liabilities | $290.68M | $275.68M | $274.32M | $73.03M | $68.86M | $62.66M |
| Retained earnings | -$1.11B | -$1.08B | -$1.02B | -$963.98M | -$861.30M | -$820.09M |
| Total equity | $319.56M | $325.88M | $372.91M | $419.46M | $502.71M | $257.19M |